Taysha Gene Therapies | DEFA14A:其他
04/18 16:27 (美东)
Taysha Gene Therapies | ARS:年度报告
04/18 16:23 (美东)
Taysha Gene Therapies | DEF 14A:股东委托书决议
04/18 16:19 (美东)
Taysha Gene Therapies | S-8:员工福利计划证券登记
03/19 16:57 (美东)
Taysha Gene Therapies | 8-K:重大事件
03/19 16:22 (美东)
Taysha Gene Therapies | 10-K:年度报表
03/19 16:18 (美东)
Taysha Gene Therapies | SC 13G/A:超过5%持股股东披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(5.6%),VHCP Co-Investment Holdings III, LLC(5.6%)等
02/14 20:48 (美东)
Taysha Gene Therapies | SC 13G/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%)等
02/14 17:31 (美东)
Taysha Gene Therapies | SC 13G:超过5%持股股东披露文件-RTW Investments, LP(9.8%),Roderick Wong, M.D.(9.8%)
02/14 07:11 (美东)
Taysha Gene Therapies | SC 13G/A:超过5%持股股东披露文件(修正)-TCG Crossover GP I, LLC(1.6%),TCG Crossover Fund I, L.P.(1.6%)等
02/09 16:31 (美东)
Taysha Gene Therapies | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(12.002%),Abigail P. Johnson(12.002%)
02/09 09:56 (美东)
Taysha Gene Therapies | 4:持股变动声明-高管 Alam Kamran
02/06 16:43 (美东)
Taysha Gene Therapies | 8-K:重大事件
01/10 00:00 (美东)
Taysha Gene Therapies | 4:持股变动声明-高管 Alam Kamran
01/04 00:00 (美东)
Taysha Gene Therapies | 4:持股变动声明-高管 Nagendran Sukumar
01/04 00:00 (美东)
Taysha Gene Therapies | 4:持股变动声明-高管 Nolan Sean P.
01/04 00:00 (美东)
Taysha Gene Therapies | 8-K:重大事件
2023/12/20 16:21 (美东)
Taysha Gene Therapies | S-8:员工福利计划证券登记
2023/12/20 16:20 (美东)
Taysha Gene Therapies | 4:持股变动声明-首席财务官 Alam Kamran
2023/12/18 16:50 (美东)
Taysha Gene Therapies | 4:持股变动声明-高管 Nagendran Sukumar
2023/12/18 16:47 (美东)
暂无数据
暂无数据